Market Overview:
The global transport protein assays kit market is expected to grow at a CAGR of 7.5% during the forecast period from 2018 to 2030. The uptake transporter kits segment is expected to dominate the market in terms of revenue share, followed by efflux transporter kits, during the forecast period. The hospital segment is expected to be the largest application segment for transport protein assays kit market during the forecast period. North America is estimated to be the largest regional market for transport protein assays kit in 2018 and it is also projected to grow at a highest CAGR during the forecast period.
Product Definition:
The Transport Protein Assays Kit is a tool that can be used to measure the activity of transport proteins. The kit allows for the determination of both the Michaelis-Menten constant (Km) and maximum velocity (Vmax) of a transport protein. This information is important for understanding how well a particular transport protein functions, as well as what conditions are necessary for optimal function.
Efflux Transporter Kits:
The efflux transporters are a group of proteins that extrude toxic compounds from cells. The main function of these proteins is to regulate the import of various toxins and xenobiotics into the cell. Some examples of efflux transporters are ABCR1, MRP2, P-glycoprotein (PGC), and multidrug resistance protein 2 (MRP2).
Uptake Transporter Kits:
Uptake Transporter Kits are used for the measurement of protein in plasma, urine, and serum. It is a colorimetric assay that utilizes an uptake inhibitor to inhibit cellular uptake of the substrate followed by its transport into the cytosol. The concentration of transported substrate can be measured using various kits available in the market based on manufacturer’s requirements.
Application Insights:
The hospital application segment accounted for the largest revenue share in 2017. The growth is attributed to the rising prevalence of diseases, such as cancer, respiratory disorders and diabetes. Moreover, an increase in healthcare spending by governments as well as private organizations is expected to boost industry growth over the forecast period.
Clinic applications are anticipated to witness a significant CAGR during the forecast period owing to increasing demand for point-of-care testing across various clinical settings including primary care clinics and laboratories. Furthermore, growing awareness about preventive healthcare along with government initiatives that support implementation of EBTs at lower costs is projected to drive this market over the coming years.
Regional Analysis:
North America accounted for the largest share of revenue in 2017 owing to the presence of a large number of global players and well-established healthcare infrastructure. Moreover, increasing efforts by government and non-government organizations to raise awareness regarding disease diagnosis & management are expected to propel demand over the forecast period.
Asia Pacific is anticipated to witness lucrative growth over the forecast period due to rising unmet clinical needs coupled with continuous R&D activities by various pharmaceutical companies aimed at development of novel therapeutics for effective treatment of various diseases. Rising incidence rate diabetes is also one among major factors responsible for regional market growth. In addition, growing medical tourism industry in emerging economies such as India & China can also be attributed towards an increase in demand protein assays products used during transport across biological membranes for accurate measurement transport activity levels across cell membranes in vivo). Furthermore, increasing investments on research & development by governments are expected drive market expansion over next eight years across Asia Pacific region.
Growth Factors:
- Increasing demand for personalized medicines
- Rising prevalence of chronic diseases
- Technological advancements in proteomics field
- Growing number of research institutes and pharmaceutical companies investing in proteomics research
- Increasing awareness about the benefits of transport protein assays
Scope Of The Report
Report Attributes
Report Details
Report Title
Transport Protein Assays Kit Market Research Report
By Type
Efflux Transporter Kits, Uptake Transporter Kits
By Application
Hospital, Clinic, Diagnostic Laboratories
By Companies
Thermo Fisher Scientific, BOAI NKY PHARMACEUTICALS, Bio-Techne, My BioSource, Merck, Charles River Laboratories, Abbkine, KAC, Molecular Devices
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
132
Number of Tables & Figures
93
Customization Available
Yes, the report can be customized as per your need.
Global Transport Protein Assays Kit Market Report Segments:
The global Transport Protein Assays Kit market is segmented on the basis of:
Types
Efflux Transporter Kits, Uptake Transporter Kits
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital, Clinic, Diagnostic Laboratories
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Thermo Fisher Scientific
- BOAI NKY PHARMACEUTICALS
- Bio-Techne
- My BioSource
- Merck
- Charles River Laboratories
- Abbkine
- KAC
- Molecular Devices
Highlights of The Transport Protein Assays Kit Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Efflux Transporter Kits
- Uptake Transporter Kits
- By Application:
- Hospital
- Clinic
- Diagnostic Laboratories
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Transport Protein Assays Kit Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
The Transport Protein Assays Kit is a set of three different assays to measure the transport of proteins across cell membranes.
Some of the key players operating in the transport protein assays kit market are Thermo Fisher Scientific, BOAI NKY PHARMACEUTICALS, Bio-Techne, My BioSource, Merck, Charles River Laboratories, Abbkine, KAC, Molecular Devices.
The transport protein assays kit market is expected to grow at a compound annual growth rate of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Transport Protein Assays Kit Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Transport Protein Assays Kit Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Transport Protein Assays Kit Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Transport Protein Assays Kit Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Transport Protein Assays Kit Market Size & Forecast, 2020-2028
4.5.1 Transport Protein Assays Kit Market Size and Y-o-Y Growth
4.5.2 Transport Protein Assays Kit Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Efflux Transporter Kits
5.2.2 Uptake Transporter Kits
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Hospital
6.2.2 Clinic
6.2.3 Diagnostic Laboratories
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Transport Protein Assays Kit Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Transport Protein Assays Kit Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Efflux Transporter Kits
9.6.2 Uptake Transporter Kits
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Hospital
9.10.2 Clinic
9.10.3 Diagnostic Laboratories
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Efflux Transporter Kits
10.6.2 Uptake Transporter Kits
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Hospital
10.10.2 Clinic
10.10.3 Diagnostic Laboratories
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Efflux Transporter Kits
11.6.2 Uptake Transporter Kits
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Hospital
11.10.2 Clinic
11.10.3 Diagnostic Laboratories
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Efflux Transporter Kits
12.6.2 Uptake Transporter Kits
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Hospital
12.10.2 Clinic
12.10.3 Diagnostic Laboratories
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Efflux Transporter Kits
13.6.2 Uptake Transporter Kits
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Hospital
13.10.2 Clinic
13.10.3 Diagnostic Laboratories
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Transport Protein Assays Kit Market: Competitive Dashboard
14.2 Global Transport Protein Assays Kit Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Thermo Fisher Scientific
14.3.2 BOAI NKY PHARMACEUTICALS
14.3.3 Bio-Techne
14.3.4 My BioSource
14.3.5 Merck
14.3.6 Charles River Laboratories
14.3.7 Abbkine
14.3.8 KAC
14.3.9 Molecular Devices
